Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| KAI Pharmaceuticals Announces Initiation of Second Phase 2 Study of KAI-4169 - MarketWatch (press release) |
 |
 |
|
MarketWatch (press release) Most ESRD patients on hemodialysis are affected by CKD-MBD, which can lead to significant morbidity and mortality, including bone pain and fractures, vascular calcification and cardiovascular events. Previous Phase 2 data have demonstrated that |
